Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean
Alicen B. Spaulding(National Institutes of Health), D.R. Harris(Westat (United States)), Ivete Martins Gomes(Universidade Iguaçu), Qilu Yu(Johns Hopkins University), George K. Siberry(Columbia University Irving Medical Center), Marisa Márcia Mussi‐Pinhata(Universidade de São Paulo), Jorge Alarcón(Medicina), Jorge Pinto(Universidade Federal de Minas Gerais), Lucy Civitello(Children's National), Rohan Hazra
Cited by 22
Related Papers
Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine
|New England Journal of Medicine|1999|553
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
|New England Journal of Medicine|2016|348
An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2016|278
Birth Prevalence and Natural History of Congenital Cytomegalovirus Infection in a Highly Seroimmune Population
|Clinical Infectious Diseases|2009|276
Hepatitis B virus infection in children and adolescents
|The Lancet. Gastroenterology & hepatology|2019|258